beta-D-Galp-(1->4)-alpha-D-Galp-(1->3)-D-Galp

Term ID

CHEBI:148482

Synonyms

(3R,4S,5S,6R)-4-[(2R,3R,4R,5R,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,5-triol
beta-D-galacto-hexopyranosyl-(1->4)-alpha-D-galacto-hexopyranosyl-(1->3)-D-galacto-hexopyranose
beta-D-galactopyranosyl-(1->4)-alpha-D-galactopyranosyl-(1->3)-D-galactopyranose
Gal(b1-4)Gal(a1-3)Gal

Definition

A galactotriose consisting of β-D-galactopyranose, α-D-galactopyranose and D-galactopyranose residues joined in sequence by (1→4) and (1→3) glycosidic bonds.

References

glygen:G22713QT
glytoucan:G22713QT
kegg.glycan:G01586

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from beta-D-Galp-(1->4)-alpha-D-Galp-(1->3)-D-Galp

Phenotype where environments contain beta-D-Galp-(1->4)-alpha-D-Galp-(1->3)-D-Galp

Phenotype modified by environments containing beta-D-Galp-(1->4)-alpha-D-Galp-(1->3)-D-Galp

Phenotype affecting beta-D-Galp-(1->4)-alpha-D-Galp-(1->3)-D-Galp

Human Disease Model